JUAN BAUTISTA FABREGAT LLUECA-rekin lankidetzan egindako argitalpenak (2)

2018

  1. Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine–erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)

    Cancer Chemotherapy and Pharmacology, Vol. 82, Núm. 6, pp. 935-943

2016

  1. Recommendations for the diagnosis, staging and treatment of pre-malignant lesions and pancreatic adenocarcinoma

    Medicina Clinica, Vol. 147, Núm. 10, pp. 465.e1-465.e8